1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Thromboprophylaxis with dalteparin in medical patients: which patients benefit?
(
- Contribution to journal › Article
- 2006
-
Mark
Outpatient tinzaparin therapy in pulmonary embolism quantified with ventilation/perfusion scintigraphy.
(
- Contribution to journal › Article
- 2005
-
Mark
Value of ventilation/perfusion SPECT detecting extensive pulmonary embolism in a patient with pneumonia.
(
- Contribution to journal › Article
-
Mark
Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients - A subgroup analysis of the PREVENT Trial
(
- Contribution to journal › Article
-
Mark
Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients
(
- Contribution to journal › Article
- 2004
-
Mark
Diagnostic evaluation of planar and tomographic ventilation/perfusion lung images in patients with suspected pulmonary emboli.
(
- Contribution to journal › Article
-
Mark
Risk factors for venous thromboembolism in hospitalized patients with acute medical illness - Analysis of the MEDENOX study
(
- Contribution to journal › Article
-
Mark
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients
(
- Contribution to journal › Article
-
Mark
Correlation of plasma coagulation parameters with thromboprophylaxis, patient characteristics, and outcome in the MEDENOX study
(
- Contribution to journal › Article
- 2003
-
Mark
MR venography using an intravascular contrast agent: results from a multicenter phase 2 study of dosage.
2003) In American Journal of Roentgenology: diagnostic imaging and related sciences 180(1). p.227-232(
- Contribution to journal › Article